Pacira Pharmaceuticals buy StockNews.com
Start price
05.08.23
/
50%
€35.80
Target price
05.08.24
-
Performance (%)
-46.93%
End price
06.08.24
€19.00
Summary
This prediction ended on 06.08.24 with a price of €19.00. Massive losses of -46.93% were the result for the BUY prediction by StockNews_com. StockNews_com has a follow-up prediction for Pacira Pharmaceuticals where he still thinks Pacira Pharmaceuticals is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | 3.571% | 3.571% | 25.405% |
| iShares Core DAX® | 1,01 % | 2,70 % | 4,36 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % | 18,00 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % | 40,91 % |
| iShares S&P 500 | -2,72 % | -1,75 % | 16,97 % |
Comments by StockNews_com for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€19.20
08.11.25
08.11.25
-
08.11.26
08.11.26
18.75%
29.07.26
29.07.26
